Multiple gene aberrations and breast cancer: lessons from super-responders
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multiple gene aberrations and breast cancer: lessons from super-responders
Authors
Keywords
Breast cancer, Genomic aberrations, Next generation sequencing
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-28
DOI
10.1186/s12885-015-1439-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms
- (2015) Mark J Axelrod et al. Oncotarget
- Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
- (2013) Kamal S. Saini et al. CANCER TREATMENT REVIEWS
- Inhibition of ERK activation enhances the repair of double-stranded breaks via non-homologous end joining by increasing DNA-PKcs activation
- (2012) Fengxiang Wei et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- PI3K independent activation of mTORC1 as a target in lapatinib-resistant ERBB2+ breast cancer cells
- (2012) Anna-Maria Jegg et al. BREAST CANCER RESEARCH AND TREATMENT
- Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones
- (2012) Andrea Cavazzoni et al. CANCER LETTERS
- PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials
- (2012) F. Janku et al. CANCER RESEARCH
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Phase I Study of the Antiangiogenic Antibody Bevacizumab and the mTOR/Hypoxia-Inducible Factor Inhibitor Temsirolimus Combined with Liposomal Doxorubicin: Tolerance and Biological Activity
- (2012) J. Moroney et al. CLINICAL CANCER RESEARCH
- Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
- (2012) A.-M. Tsimberidou et al. CLINICAL CANCER RESEARCH
- Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes
- (2012) Michael A. Augello et al. JOURNAL OF CLINICAL INVESTIGATION
- PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies HarboringPIK3CAMutations
- (2012) Filip Janku et al. JOURNAL OF CLINICAL ONCOLOGY
- Biological mechanisms and clinical implications of endocrine resistance in breast cancer
- (2011) Mario Giuliano et al. BREAST
- PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression
- (2011) Kevin Kalinsky et al. BREAST CANCER RESEARCH AND TREATMENT
- A Phase I Trial of Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Patients with Advanced Gynecologic and Breast Malignancies
- (2011) J. W. Moroney et al. CLINICAL CANCER RESEARCH
- Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer
- (2011) Todd W. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- ER and PI3K Independently Modulate Endocrine Resistance in ER-Positive Breast Cancer
- (2011) B. A. Van Tine et al. Cancer Discovery
- Insulin Receptor Substrate Regulation of Phosphoinositide 3-Kinase
- (2010) H. E. Metz et al. CLINICAL CANCER RESEARCH
- Chemotherapy Resistance and Retreatment: A Dogma Revisited
- (2010) Aung Naing et al. Clinical Colorectal Cancer
- Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer
- (2010) Todd W. Miller et al. JOURNAL OF CLINICAL INVESTIGATION
- Convergence between Wnt-β-catenin and EGFR signaling in cancer
- (2010) Tianhui Hu et al. Molecular Cancer
- Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors
- (2009) Jeremy M. Arnold et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer
- (2008) Henna Heinonen et al. BMC GENOMICS
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
- MYC in breast tumor progression
- (2008) Yinghua Chen et al. Expert Review of Anticancer Therapy
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started